Search results for: sleep

Orexin’s Yin/Yang Functions Regulate Bone Remodeling

Lara C. Pullen, PhD | July 3, 2014

Working both to support bone formation and suppress it, a new study reveals orexin neuropeptides are essential regulators of skeletal homeostasis

Rheumatology Drug Updates, Trials, Safety Data

Michele B. Kaufman, PharmD, BCGP | July 1, 2014

An update on baricitinib, plus safety warnings on belimumab,
eszopiclone and zoledronic acid

How to Manage Physician Burnout

Vanessa Caceres | July 1, 2014

Stress-coping techniques for physicians under strain of healthcare industry changes

Rheumatologists Make Progress Defining Spectrum of Axial Spondyloarthritis

Atul Deodhar, MD | May 1, 2014

New research clarifies terminology used for diagnosis, but questions remain around epidemiology, genetics and management of patients with axial skeletal inflammation

Tips for Treating Pain, Depression in Patients with Rheumatic Disease Offered at the ACR/ARHP’s 2013 Annual Meeting

Susan Bernstein | April 2, 2014

Observational pain scales, diagnostic tools, pharmacologic interventions, and support from psychologists, caregivers recommended

Methotrexate May Mitigate Inflammatory Bone Disease Note Experts at the ACR/ARHP Winter Rheumatology Symposium

Kimberly Retzlaff | April 2, 2014

By regulating molecules key to osteoclast/osteoblast processes, methotrexate may reduce bone destruction in inflammatory arthritis, osteolysis, especially in combination with adenosine

Mobile Health Devices May Have Limited Use in Rheumatology

Simon M. Helfgott, MD | April 2, 2014

Challenges exist in developing m-health apps for rheumatology patients because of the difficulty in pinpointing what needs to be measured

Exploring Kawasaki Disease

Mary Beth Son, MD | April 2, 2014

New epidemiologic data, clinical studies have shed light on diagnosis, treatments, patient outcomes for this childhood disease, but etiology is still unknown

What Role Does Fascia Play in Rheumatic Diseases?

Helene M. Langevin, MD | March 1, 2014

Recent research explores possible connections between abnormalities in fasciae and painful musculoskeletal conditions such as chronic back pain, osteoarthritis, and rheumatoid arthritis, as well as scleroderma

Rheuminations: Rheumatologists Seek Better Understanding of Fibrosing Disorders

Simon M. Helfgott, MD | December 1, 2013

Research into scleroderma, fibrosis, and Raynaud’s phenomenon may provide clues into the pathogenesis of systemic sclerosis